Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

BUY
$27.56 - $37.75 $1,019 - $1,396
37 New
37 $1,000
Q1 2022

May 04, 2022

SELL
$22.96 - $36.45 $1,515 - $2,405
-66 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$18.14 - $23.29 $1,197 - $1,537
66 New
66 $1.54 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.78B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Absolute Capital Management, LLC Portfolio

Follow Absolute Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Absolute Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Absolute Capital Management, LLC with notifications on news.